Actively Recruiting

Phase 2
Age: 18Years - 65Years
All Genders
NCT07311564

A Study of LAD603 in Adults With Alopecia Areata

Led by Almirall, S.A. · Updated on 2026-01-12

136

Participants Needed

1

Research Sites

100 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The main aim of the study is to evaluate the effect of LAD603 in adult participants with severe to very severe alopecia areata (AA). The study will also evaluate the safety, pharmacokinetics (PK), immunogenicity and pharmacodynamic (PD) biomarkers of LAD603.

CONDITIONS

Official Title

A Study of LAD603 in Adults With Alopecia Areata

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female between 18 and 65 years old at informed consent
  • Severe to very severe alopecia areata with 50% or more scalp hair loss measured by SALT, without terminal hair regrowth within 6 months at screening and baseline
  • Current hair loss episode lasting at least 6 months but no longer than 7 years
  • Agreement to pregnancy avoidance if female of childbearing potential or male participant
Not Eligible

You will not qualify if you...

  • Other types of alopecia such as traction or scarring alopecia
  • Diffuse alopecia areata
  • Active inflammatory skin diseases like psoriasis, seborrheic dermatitis, or lupus interfering with alopecia assessment
  • Previous severe reaction to subcutaneous medication
  • Elevated liver enzymes (ALT or AST ≥ 2.5 × ULN)
  • Total bilirubin ≥ 1.5 × ULN (≥ 3 × ULN if Gilbert's syndrome)
  • Alkaline phosphatase ≥ 1.5 × ULN
  • Use of prohibited medications or failure to complete required washout periods

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Investigator Site 1

Omaha, Nebraska, United States, 68144

Actively Recruiting

Loading map...

Research Team

D

Davide Carluccio

CONTACT

E

Estrella García

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here